Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorDUMAS DE LA ROQUE, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPREZELIN-REYDIT, Mathilde
dc.contributor.authorVERMOREL, A.
dc.contributor.authorLEPREUX, S.
dc.contributor.authorDEMINIERE, C.
dc.contributor.authorCOMBE, C.
dc.contributor.authorRIGOTHIER, C.
dc.date.accessioned2020-11-09T09:18:16Z
dc.date.available2020-11-09T09:18:16Z
dc.date.issued2018-09-09
dc.identifier.issn2077-0383 (Print)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/12139
dc.description.abstractEnThere are various histopathological forms of idiopathic nephrotic syndrome, including minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS). Whereas some relapse predictor factors have been identified in renal transplantation, the clinical future of idiopathic nephrotic syndrome in the native kidney remains uncertain. We designed a multicentric retrospective descriptive cohort study including all patients aged 15 years and over whose renal biopsy confirmed MCD or FSGS between January 2007 and December 2014. We studied 165 patients with idiopathic nephrotic syndrome; 97 with MCD and 68 with FSGS. In the MCD cohort, 91.7% of patients were treated with corticosteroids for a median total duration of 13 months. During 45 months of follow-up, 92.8% of patients achieved remission and 45.5% experienced relapse. In this cohort, 5% of patients experienced terminal kidney disease. With respect to FSGS patients, 51.5% were treated with corticosteroids for a median total duration of 15 months. During 66 months of follow-up, 73.5% of patients achieved remission and 20% experienced relapse. In this cohort, 26.5% of patients experienced terminal kidney disease. No statistical association was observed between clinical and biological initial presentation and relapse occurrence. This study describes the characteristics of a cohort of patients with the nephrotic idiopathic syndromes of MCD and FSGS from the time of renal biopsy and throughout follow-up.
dc.language.isoENen_US
dc.rightsAttribution 4.0 International (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.enCIC1401
dc.title.enIdiopathic Nephrotic Syndrome: Characteristics and Identification of Prognostic Factors
dc.title.alternativeJ Clin Meden_US
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/jcm7090265en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30205613en_US
bordeaux.journalJournal of Clinical Medicineen_US
bordeaux.volume7en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue9en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03164706
hal.version1
hal.date.transferred2021-03-10T09:25:20Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Clinical%20Medicine&rft.date=2018-09-09&rft.volume=7&rft.issue=9&rft.eissn=2077-0383%20(Print)&rft.issn=2077-0383%20(Print)&rft.au=DUMAS%20DE%20LA%20ROQUE,%20C.&PREZELIN-REYDIT,%20Mathilde&VERMOREL,%20A.&LEPREUX,%20S.&DEMINIERE,%20C.&rft.genre=article


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record